Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

CGEM

Cullinan Therapeutics, Inc.

CIK 0001789972 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$18.38
↓ 0.05 (-0.27%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$1.13B
P/E Ratio
-5.11
EPS
Not covered
Dividend Yield
Not covered
52W Position
92%
Beta
1.45

Valuation multiples

Fwd P/E
6.74
PEG
Not covered
P/B
3.08
P/S
Not covered
EV/Revenue
Not covered
ROE
-60.4%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 92%
$5.68$19.43

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$219.88M
Total Assets
$448.37M
Free Cash Flow
-$175.80M

Recent news